<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: Shrinking lung syndrome is characterized by pulmonary compromise secondary to unilateral or bilateral <z:hpo ids='HP_0003470'>paralysis</z:hpo> of the diaphragm </plain></SENT>
<SENT sid="1" pm="."><plain>CASE: Shrinking lung syndrome was diagnosed in a patient with <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> after a cesarean delivery at 28 4/7 weeks of gestation </plain></SENT>
<SENT sid="2" pm="."><plain>Signs and symptoms included unexplained right-side <z:hpo ids='HP_0100749'>chest pain</z:hpo>, <z:hpo ids='HP_0002094'>dyspnea</z:hpo>, <z:hpo ids='HP_0002789'>tachypnea</z:hpo>, and absent breath sounds at the right base of the lungs </plain></SENT>
<SENT sid="3" pm="."><plain>After initiation of <z:chebi fb="0" ids="50858">corticosteroids</z:chebi>, her symptoms resolved </plain></SENT>
<SENT sid="4" pm="."><plain>CONCLUSION: Although seen in association with <z:hpo ids='HP_0002725'>systemic lupus erythematosus</z:hpo>, shrinking lung syndrome has not been described with <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> or during pregnancy </plain></SENT>
<SENT sid="5" pm="."><plain>Diagnosis and awareness are important because treatment with moderate- to high-dose <z:chebi fb="0" ids="50858">corticosteroids</z:chebi> appears to improve the clinical outcome </plain></SENT>
</text></document>